 | Immunic, Inc. | |||
| NMS : IMUX || Location: United States | ||||
$1.240.0 (0.0%) |
0.13 M | 1.22 - 1.29 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 3.031 M |
| March 15, 2024 | 2.474 M |
| Feb. 29, 2024 | 2.219 M |
| Feb. 15, 2024 | 2.524 M |
| Jan. 31, 2024 | 2.594 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.52 | -0.48 | 8.31% |
| 09/30/2023 | -0.56 | -0.51 | 8.68% |
| 06/30/2023 | -0.53 | -0.54 | -1.03% |
| 03/31/2023 | -0.53 | -0.58 | -9.66% |
| 12/31/2022 | -0.75 | -1.62 | -116.61% |
IMUX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 89.929M | Shares Float | 49.384M |
| Short Float | 3.031M | Market Cap | 111.51M |
| Institution ownership | 58.06% | Insider ownership | 7.717% |
| Earnings Date | 05/09/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -2.11 | Forward EPS | -0.92 |